Abstract
ObjectiveTo develop an end-to-end clinical trial service to improve patient experience during trials, reduce the burden of participating in a trial, and increase trial retention.MethodsA literature search and stakeholder interviews were used to identify current challenges and unmet needs of systemic lupus erythematosus patients and other systemic lupus erythematosus clinical trial stakeholders. The results from the literature search and interviews were used to create a five-phase map describing the current clinical trial experience of all stakeholders. A set of proposed solutions were developed to address the identified unmet needs and challenges. These solutions were presented to trial-experienced patients and study site personnel; any feedback obtained was used to further refine the solutions.ResultsFour site personnel and seven patients from three different systemic lupus erythematosus clinical trial sites were interviewed between September 2015 and December 2015. Key unmet needs and challenges were identified at each stage of the clinical trials. At the screening stage, some patients incorrectly thought they were successfully enrolled into the clinical trial. During enrollment, some patients found it difficult to keep fully informed about the trial and were unable to explain the trial process to loved ones. During the trial, patients struggled to prepare for study visits, felt overwhelmed by the trial process, and wanted someone to talk to for support. Clinical trial site personnel reported current key challenges as: delivering trial information clearly and consistently to patients, setting patient expectations, retaining enrolled patients, and providing non-clinical patient support. To address the needs of patients and site personnel, an end-to-end support service was designed, consisting of nine solutions: My Best Choice, My Eligibility, My Lupus Trial Kit, My Lupus Trial Coach, My Appointment Guide, My Clinic Compass, Our Gratitude, Building a Different Network, and My Next Chapter.ConclusionThe solutions proposed in this qualitative study may help improve the systemic lupus erythematosus clinical trial experience for patients, potentially helping to increase trial recruitment and retention. The solutions proposed here would also promote positive patient-trial personnel relationships, which may help site personnel identify patients at risk of early withdrawal, while ensuring that the time and resources of site personnel are used efficiently.
Highlights
Clinical trials are necessary to evaluate the safety and efficacy of new interventions in the prevention and treatment of disease.[1]
The needs of and challenges faced by patients and other stakeholders in Systemic lupus erythematosus (SLE) clinical trials were determined through a search of academic and gray literature, and via interviews conducted with stakeholders including patients, trial site personnel and sponsors
Articles were available in English The abstract contained information in relation to patient experience, either in conjunction with the clinical trial experience, or medication adherence Articles related to patients with any chronic or non-communicable disease
Summary
Clinical trials are necessary to evaluate the safety and efficacy of new interventions in the prevention and treatment of disease.[1] For adequately powered clinical trials, large numbers of participants are often required.[2] This can pose a challenge as factors such as the high number of appointments, inpatient hospital stays, and perceived discomfort from medical procedures can lead to poor recruitment and adherence, and high rates of patient drop-out.[1,2,3,4,5] Poor participant recruitment and retention can result in clinical trial delays, which can lead to increased trial costs and increased risk of trial failure.[3] Implementing small changes that reduce the Clinical Trials 16(1). Systemic lupus erythematosus (SLE) is a chronic systemic autoimmune disease affecting multiple organs, including the kidneys and central nervous system.[6,7]
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.